ILE A 86TRP A 87LEU A 170ASP A 202LEU A 205GLY A 206PHE A 209TYR A 242MET A 295
CB3 A 768 (-3.6A)NoneUMP A 767 (-4.7A)CB3 A 768 ( 3.6A)CB3 A 768 ( 4.4A)UMP A 767 (-3.7A)CB3 A 768 (-3.6A)CB3 A 768 ( 4.7A)CB3 A 768 (-3.8A)
1.04A
3k2hA-1ci7A:0.0
3k2hA-1ci7A:32.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LYS A 42GLY A 65ALA A 67GLU A 88SER A 90ASP A 113ALA A 114ASP A 133GLN A 136
SAM A 301 (-3.0A)SAM A 301 ( 3.8A)SAM A 301 (-3.1A)SAM A 301 (-2.4A)SAM A 301 ( 4.9A)SAM A 301 (-3.6A)SAM A 301 (-3.4A)SAM A 301 (-3.7A)SAM A 301 (-3.4A)
0.67A
3nmuA-1nt2A:0.23nmuF-1nt2A:21.3
3nmuA-1nt2A:21.393nmuF-1nt2A:42.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LYS E 57GLY E 81GLU E 105PHE E 106SER E 107ASP E 130ALA E 131ASP E 150GLN E 153
C X 5 ( 2.7A)NoneNoneNone G A 22 ( 2.7A)NoneNone C X 5 ( 3.2A) G A 24 ( 3.0A)
1.03A
3nmuA-4by9E:undetectable3nmuF-4by9E:34.7
3nmuA-4by9E:22.513nmuF-4by9E:97.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLU A 381ILE A 402TRP A 403ASN A 406ASP A 513LEU A 516GLY A 517TYR A 553MET A 608
CB3 A 703 ( 4.1A)CB3 A 703 (-3.4A)CB3 A 703 (-4.1A)CB3 A 703 (-4.2A)CB3 A 703 ( 3.8A)CB3 A 703 (-3.7A)CB3 A 703 ( 3.0A)UMP A 701 (-4.4A)CB3 A 703 (-3.6A)
0.42A
3nrrA-5t0lA:undetectable
3nrrA-5t0lA:42.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ILE A 402TRP A 403ASN A 406ASP A 513LEU A 516GLY A 517PHE A 520TYR A 553MET A 608
CB3 A 703 (-3.4A)CB3 A 703 (-4.1A)CB3 A 703 (-4.2A)CB3 A 703 ( 3.8A)CB3 A 703 (-3.7A)CB3 A 703 ( 3.0A)CB3 A 703 (-3.8A)UMP A 701 (-4.4A)CB3 A 703 (-3.6A)
0.77A
3nrrA-5t0lA:undetectable
3nrrA-5t0lA:42.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLU A 381ILE A 402TRP A 403ASN A 406ASP A 513LEU A 516GLY A 517TYR A 553MET A 608
CB3 A 703 ( 4.1A)CB3 A 703 (-3.4A)CB3 A 703 (-4.1A)CB3 A 703 (-4.2A)CB3 A 703 ( 3.8A)CB3 A 703 (-3.7A)CB3 A 703 ( 3.0A)UMP A 701 (-4.4A)CB3 A 703 (-3.6A)
0.42A
3nrrB-5t0lA:undetectable
3nrrB-5t0lA:42.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ILE A 402TRP A 403ASN A 406ASP A 513LEU A 516GLY A 517PHE A 520TYR A 553MET A 608
CB3 A 703 (-3.4A)CB3 A 703 (-4.1A)CB3 A 703 (-4.2A)CB3 A 703 ( 3.8A)CB3 A 703 (-3.7A)CB3 A 703 ( 3.0A)CB3 A 703 (-3.8A)UMP A 701 (-4.4A)CB3 A 703 (-3.6A)
0.79A
3nrrB-5t0lA:undetectable
3nrrB-5t0lA:42.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 21TYR A 24GLU A 67SER A 122ARG A 134LEU A 163VAL A 165ILE A 192LEU A 195
SAM A 504 (-4.6A)SAM A 504 ( 3.4A)SAM A 504 (-4.1A)SAM A 504 (-2.5A)SAM A 504 ( 3.5A)SAM A 504 (-3.8A)SAM A 504 (-4.7A)SAM A 504 (-4.0A)SAM A 504 (-4.1A)
0.28A
4k38A-4k37A:60.54k38D-4k37A:undetectable
4k38A-4k37A:100.004k38D-4k37A:5.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.